13/12/2025
Among the 14 collectives commended under the official decision, Traphaco and Traphaco Hung Yen were the two representatives from the pharmaceutical manufacturing sector, recognized alongside leading drug testing institutions and frontline quality control centers nationwide.

The representative of Traphaco receives the Certificate of Commendation from the National Institute of Drug Quality Control
In 2025, Traphaco continued to be acknowledged for its testing capacity and quality control performance through its participation in the Proficiency Testing Program via interlaboratory comparison organized by the National Institute of Drug Quality Control (NIDQC). According to Decision No. 1697/QĐ-VKNTTW dated December 8, 2025, issued by the Director of the NIDQC, both Traphaco Joint Stock Company and Traphaco Hung Yen Co., Ltd. were awarded Certificates of Commendation for “outstanding performance in the 2025 interlaboratory proficiency testing program.” This recognition represents a clear professional validation, reflecting the company’s testing practices within a structured competency assessment framework involving multiple participating laboratories, thereby affirming the reliability of the test results provided by Traphaco within Vietnam’s pharmaceutical quality control system.

Traphaco continues to be recognized for its testing capabilities and quality control performance

In-situ UV fiber optics spectrophotometer (Distek, USA), delivering real-time analytical results
Interlaboratory proficiency testing programs play a significant role for testing laboratories and pharmaceutical manufacturers. By analyzing test samples under the same standards, methods, and controlled conditions, the results from each participating unit are compared against reference values or consensus values derived from multiple laboratories. This process enables an objective evaluation of accuracy, repeatability, error control capability, and the ability to operate testing procedures in accordance with professional standards. Achieving outstanding results in such a program does not merely reflect strong performance in a single measurement, but rather demonstrates the capacity to maintain a stable and consistent testing system throughout the entire process — from sample preparation and equipment operation to instrument calibration, compliance with standard operating procedures, and the professional competence of personnel.
In its sustainable development orientation, Traphaco consistently regards quality as a core factor underpinning its brand credibility. Professional recognitions from leading authorities serve as motivation for the company to continue maintaining and improving its testing capabilities, enhancing the effectiveness of its quality management system, and increasingly meeting the expectations of both the market and regulatory bodies.

Decision on the awarding of the Certificate of Commendation issued by the National Institute of Drug Quality Control
TRAPHACO
MOST VIEWED POSTS
Concerned posts